文献速递慢性静脉疾病

症状驱动的自上而下与自下而上策略治疗盆腔源性盆外静脉曲张的结局

Outcomes of Symptom-Driven Top-Down versus Bottom-Up Strategies for Pelvic-Origin Extra-Pelvic Varicose Veins.
PubMed 文献 · Ann Vasc Surg · 2026-07-29

3个月时两组rVCSS、CIVIQ-20、逃逸点闭塞率、症状缓解率均无显著差异。5年无复发生存率无显著差异(log-rank P=0.33),BMI为复发显著预测因子(HR=2.654,P=0.015)。

要点

  • 症状驱动选择自上而下或自下而上策略,短期结局与中期耐久性均良好
  • 3个月时两组rVCSS与CIVIQ-20评分差异无统计学意义
  • BMI是复发的显著预测因子(HR=2.654,P=0.015)

核心结论

  • 在临床选择的患者中,症状驱动的自上而下与自下而上策略均与良好的短期结局和中期耐久性相关。
  • 两组代表不同临床表型而非随机可比人群,结果不能解释为等效性证据。
  • 治疗选择应基于盆腔症状、盆腔血流动力学和盆外解剖模式个体化制定。

研究设计与样本

  • 自上而下组32例,自下而上组43例。
  • 诊断基于临床检查、双功超声和盆腔静脉影像。
  • 有临床相关盆腔症状者一般采用自上而下策略,以盆外表现为主且无明显盆腔症状者采用自下而上策略。

主要发现

  • 3个月时两组rVCSS和CIVIQ-20评分差异无统计学意义(P=0.71和P=0.86)。
  • 逃逸点闭塞率分别为93.8%和97.7%(P=0.58)。
  • 下肢症状缓解率分别为100%和95.3%(P=0.24),外阴静脉曲张缓解率分别为87.5%和93.0%(P=0.47)。
  • 3年随访复发率自上而下组为6.25%,自下而上组为11.6%。
  • 5年无复发生存率两组差异无统计学意义(log-rank P=0.33),Cox回归显示BMI为复发显著预测因子(HR=2.654,P=0.015)。

临床怎么用

  • 可根据盆腔症状、盆腔血流动力学及盆外解剖模式个体化选择自上而下或自下而上策略。
  • 术后随访应关注复发,尤其对BMI较高的患者。

局限性

  • 回顾性设计,两组代表不同临床表型而非随机可比人群。
  • 结果不能作为两种策略等效性的证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pelvic-origin extra-pelvic varicose veins are increasingly recognized as a distinct phenotype of chronic venous disease. The optimal treatment sequence remains uncertain and is often selected according to the dominant clinical presentation. This study evaluated outcomes after symptom-driven top-down or bottom-up strategies in women with pelvic-origin extra-pelvic varicose veins. METHODS: We reviewed consecutive women with pelvic-origin extra-pelvic varicose veins treated between 2018 and 2024. Diagnosis was based on clinical examination, duplex ultrasound, and pelvic venous imaging. Patients with clinically relevant pelvic symptoms were generally treated with a top-down strategy, whereas patients with predominantly extra-pelvic manifestations and no significant pelvic symptoms were treated with a bottom-up strategy. Extra-pelvic outcomes were assessed using the revised Venous Clinical Severity Score (rVCSS), the Chronic Venous Insufficiency Questionnaire-20 (CIVIQ-20), technical success, escape point occlusion, and recurrence-free survival. Pelvic pain response in the top-down group was assessed using the visual analog scale (VAS) and parauterine vein diameter. RESULTS: Seventy-five patients were included: 32 in the top-down group and 43 in the bottom-up group. The groups had similar baseline characteristics, except for age (bottom-up group was older). At 3 months, no statistically significant differences were observed in rVCSS and CIVIQ-20 scores between the selected treatment groups (P = 0.71 and P = 0.86, respectively). Escape point occlusion rates were 93.8% and 97.7% (P = 0.58), lower limb symptom resolution rates were 100% and 95.3% (P = 0.24), and vulvar varices resolution rates were 87.5% and 93.0% (P = 0.47), respectively. At 3-year follow-up, the recurrence rate was 6.25% in the top-down group and 11.6% in the bottom-up group. Recurrence-free survival rates at 5 years were not statistically different between the groups (log-rank P = 0.33). Cox regression analysis identified BMI as a significant predictor of recurrence (HR = 2.654, P = 0.015). CONCLUSION: In this retrospective cohort of clinically selected patients, symptom-driven top-down and bottom-up strategies were both associated with favorable short-term outcomes and mid-term durability. Because the two groups represented different clinical phenotypes rather than randomized comparable populations, these findings should not be interpreted as proof of equivalent effectiveness. Treatment selection should be individualized based on pelvic symptoms, pelvic hemodynamics, and extra-pelvic anatomical patterns.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Li X, Jing Z, Shan S, et al. Outcomes of Symptom-Driven Top-Down versus Bottom-Up Strategies for Pelvic-Origin Extra-Pelvic Varicose Veins. Ann Vasc Surg. 2026. PMID: 42526747. doi:10.1016/j.avsg.2026.07.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。